Domainex is a fully integrated drug discovery service company based near Cambridge, UK serving pharmaceutical, biotechnology, academic and patient foundations globally. Our expertise and commitment to providing high quality services has resulted in a strong success record in drug discovery, delivering an average one candidate drug every year for the past six years. Domainex’s highly experienced molecular, protein, structural and assay biologists plus medicinal, computational and analytical chemists can be leveraged through our CRO services. Domainex’s focus is on providing highly efficient and well considered scientific solutions to enable successful drug discovery programmes against a wide range of drug targets. Domainex offers a range of services including: • Medicinal chemistry (including SBDD) • FragmentBuilder (Domainex’s proprietary fragment screening platform) • Computational Chemistry (including LeadBuilder Domainex’s proprietary virtual screening platform) • Assay Development and Screening (biochemical, biophysical and cell assays) • iPSC and immune cell biology • Protein Production • CDH (Domainex’s proprietary technology which enables the rapid identification of stable, soluble protein domains) • Analytical chemistry • X-ray crystallography services Whether your project is at an early stage of drug discovery or has already identified chemical matter, our processes have been shown to result in a 30% time-saving compared to industry standards and use less resource, allowing prudent management of your own budget.
View Top Employees from DomainexWebsite | http://www.domainex.co.uk |
Revenue | $15 million |
Employees | 119 (118 on RocketReach) |
Founded | 2002 |
Phone | +44 1223 743170 |
Technologies |
JavaScript,
HTML,
Twitter
+14 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Drug Discovery, Business Services, Computational chemistry, Medicinal chemistry, Molecular Biology, Epigenetics, Oncology, Kinase inhibitor research, Protease inhibitor research, Protien-Protein Interactions |
Keywords | Drug Development And Manufacturing, Medicinal Chemistry, Analytical Chemistry |
Competitors | IRBM, Provid Pharmaceuticals, Shanghai Yongchuang Medical Instrument Co. Ltd, Sygnature Discovery, Synovo |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular Domainex employee's phone or email?
The Domainex annual revenue was $15 million in 2024.
David Cronk is the COO of Domainex.
118 people are employed at Domainex.
The NAICS codes for Domainex are [5417, 54171, 541714, 541, 54].
The SIC codes for Domainex are [87, 873].